Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what representations he has received on the availability of new medications to alleviate the condition of people with MS on the NHS.

A search of the Department’s Ministerial correspondence database has identified four items of correspondence received since November 2016 about the availability of new medications to alleviate the condition of people with multiple sclerosis on the National Health Service. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.

There have also been two Lords Written Parliamentary Questions.

The National Institute for Health and Care Excellence is currently developing guidance on the use of cladribine for treating multiple sclerosis and expects to publish final guidance on 6 December.